Urology

Our lab aims to characterize epigenetic regulators promoting survival, adaptability and metastasis of lethal cancers, particularly hormone refractory prostate cancers and characterize novel small molecule inhibitors that we have identified as having potent anti-tumor activity against metastatic prostate cancers.

Our lab aims to determine how tyrosine kinases, phosphatases, demethylases and nuclear receptors regulate epigenetic processes that affect cellular homeostasis, immune impairment and cancer.